For UK Consultants & Registrars in Dermatology and Plastic Surgery
Clinical decision support for UK skin oncology. From AJCC 8th staging and risk scoring to secure clinical photography, lesion localisation, and patient information resources.
Selected modules from the wider Dermafocal clinical toolkit.
Differential diagnosis support and risk stratification for trained clinicians.
Structured management outputs and MDT-oriented guidance across key tumour pathways.
AJCC 8th staging and risk tools for melanoma, cSCC, Merkel cell carcinoma, adnexal carcinoma, sarcoma, and more.
Secure local-first clinical photography with consent-aware workflow and record export.
Anatomical lesion localisation and site documentation to support accurate record keeping.
Condition and procedure leaflets for diagnosis, surgery, aftercare, and consent support.
Dermafocal is built for UK clinical practice across both NHS and private settings, with emphasis on patient safety, regulatory clarity, and local-first data handling. Developed by a UK consultant plastic surgeon specialising in skin oncology.
Class I Medical Device (Ref: 2026020301462324). UKCA Marked. Verify on MHRA
Clinical safety documentation, hazard logging, and governance review maintained to support safe deployment.
Structured to support DTAC-aligned procurement and deployment discussions with NHS organisations.
Local-first architecture keeps Derma Capture records on device in normal operation and avoids a routine central clinical storage backend.
We can support departmental licensing conversations via Apple Business Manager or direct procurement discussion.
Every clinical engine in Dermafocal has been individually verified against its published guideline source.
Every staging engine, risk stratification algorithm, and dose calculator is covered by automated boundary-condition testing. All tests pass with zero failures.
All clinical thresholds, staging grid cells, and margin values independently verified against AJCC 8th Edition, BAD 2020/2021, NICE NG14, NCCN, and BNF publications. Zero clinical errors in the final audit.
Every clinical tool displays its guideline source directly on screen, so you can always verify the evidence base behind any output.
Full DCB0129-compliant hazard log maintained with risk controls documented for every identified clinical hazard. All residual risks reduced to acceptable or ALARP levels.
Individual subscriptions for clinicians, with annual pricing offering the best value.